nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—Effects of Nitric Oxide—NOS1—obesity	0.0183	0.0989	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—GLRX—obesity	0.0126	0.0681	CbGpPWpGaD
Deferoxamine—XDH—Purine catabolism—GPX1—obesity	0.0114	0.0616	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS3—obesity	0.00878	0.0474	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—GPX3—obesity	0.00852	0.046	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—NQO1—obesity	0.00646	0.0349	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—HMOX1—obesity	0.00531	0.0287	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—SOD2—obesity	0.00497	0.0268	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—GPX1—obesity	0.00474	0.0256	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—GPX1—obesity	0.00439	0.0237	CbGpPWpGaD
Deferoxamine—Vision blurred—Diethylpropion—obesity	0.00426	0.00523	CcSEcCtD
Deferoxamine—Oedema—Phentermine—obesity	0.00424	0.00521	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Bupropion—obesity	0.00421	0.00517	CcSEcCtD
Deferoxamine—Hypersensitivity—Benzphetamine—obesity	0.0042	0.00515	CcSEcCtD
Deferoxamine—Hypotension—Phenylpropanolamine—obesity	0.00414	0.00509	CcSEcCtD
Deferoxamine—Tachycardia—Phentermine—obesity	0.00414	0.00508	CcSEcCtD
Deferoxamine—Delusion—Topiramate—obesity	0.00413	0.00507	CcSEcCtD
Deferoxamine—Abdominal pain—Phendimetrazine—obesity	0.0041	0.00504	CcSEcCtD
Deferoxamine—XDH—Nucleotide metabolism—DPYD—obesity	0.00409	0.0221	CbGpPWpGaD
Deferoxamine—Leukopenia—Diethylpropion—obesity	0.00405	0.00497	CcSEcCtD
Deferoxamine—Diarrhoea—Methamphetamine—obesity	0.00404	0.00496	CcSEcCtD
Deferoxamine—Renal impairment—Sibutramine—obesity	0.00401	0.00492	CcSEcCtD
Deferoxamine—Dyspnoea—Phenylpropanolamine—obesity	0.00395	0.00485	CcSEcCtD
Deferoxamine—Anaphylactoid reaction—Sibutramine—obesity	0.00395	0.00484	CcSEcCtD
Deferoxamine—Convulsion—Diethylpropion—obesity	0.00392	0.00481	CcSEcCtD
Deferoxamine—Dizziness—Methamphetamine—obesity	0.00391	0.00479	CcSEcCtD
Deferoxamine—Diarrhoea—Benzphetamine—obesity	0.0039	0.00478	CcSEcCtD
Deferoxamine—Leukopenia—Cimetidine—obesity	0.00385	0.00473	CcSEcCtD
Deferoxamine—Myalgia—Diethylpropion—obesity	0.00385	0.00473	CcSEcCtD
Deferoxamine—Scotoma—Topiramate—obesity	0.00385	0.00472	CcSEcCtD
Deferoxamine—Hepatic function abnormal—Bupropion—obesity	0.00381	0.00468	CcSEcCtD
Deferoxamine—Dizziness—Benzphetamine—obesity	0.00377	0.00462	CcSEcCtD
Deferoxamine—Headache—Methamphetamine—obesity	0.0037	0.00454	CcSEcCtD
Deferoxamine—Myalgia—Cimetidine—obesity	0.00366	0.0045	CcSEcCtD
Deferoxamine—Arthralgia—Cimetidine—obesity	0.00366	0.0045	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Phentermine—obesity	0.00366	0.0045	CcSEcCtD
Deferoxamine—Tachycardia—Diethylpropion—obesity	0.0036	0.00442	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX3—obesity	0.0036	0.0195	CbGpPWpGaD
Deferoxamine—Blood creatinine increased—Sibutramine—obesity	0.00358	0.00439	CcSEcCtD
Deferoxamine—Headache—Benzphetamine—obesity	0.00357	0.00438	CcSEcCtD
Deferoxamine—Diarrhoea—Phendimetrazine—obesity	0.00355	0.00436	CcSEcCtD
Deferoxamine—Visual disturbance—Bupropion—obesity	0.00351	0.00431	CcSEcCtD
Deferoxamine—Anaphylactic shock—Cimetidine—obesity	0.00351	0.00431	CcSEcCtD
Deferoxamine—Thrombocytopenia—Cimetidine—obesity	0.00344	0.00422	CcSEcCtD
Deferoxamine—Dizziness—Phendimetrazine—obesity	0.00343	0.00421	CcSEcCtD
Deferoxamine—Tachycardia—Cimetidine—obesity	0.00343	0.00421	CcSEcCtD
Deferoxamine—Asthma—Orlistat—obesity	0.00341	0.00419	CcSEcCtD
Deferoxamine—Nausea—Benzphetamine—obesity	0.00338	0.00415	CcSEcCtD
Deferoxamine—Urticaria—Phentermine—obesity	0.00337	0.00414	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Diethylpropion—obesity	0.00336	0.00413	CcSEcCtD
Deferoxamine—Abdominal pain—Phentermine—obesity	0.00335	0.00412	CcSEcCtD
Deferoxamine—Asthma—Sibutramine—obesity	0.0033	0.00405	CcSEcCtD
Deferoxamine—Dyspnoea—Diethylpropion—obesity	0.00329	0.00404	CcSEcCtD
Deferoxamine—Abdominal discomfort—Orlistat—obesity	0.00327	0.00401	CcSEcCtD
Deferoxamine—Eosinophilia—Sibutramine—obesity	0.00327	0.00401	CcSEcCtD
Deferoxamine—Hypersensitivity—Phenylpropanolamine—obesity	0.00327	0.00401	CcSEcCtD
Deferoxamine—Headache—Phendimetrazine—obesity	0.00325	0.00399	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Cimetidine—obesity	0.0032	0.00393	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Diethylpropion—obesity	0.00319	0.00391	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—SCARB1—obesity	0.00311	0.0168	CbGpPWpGaD
Deferoxamine—Dysuria—Sibutramine—obesity	0.00309	0.00379	CcSEcCtD
Deferoxamine—Nausea—Phendimetrazine—obesity	0.00308	0.00378	CcSEcCtD
Deferoxamine—Bone pain—Topiramate—obesity	0.00305	0.00374	CcSEcCtD
Deferoxamine—Infestation NOS—Orlistat—obesity	0.00304	0.00373	CcSEcCtD
Deferoxamine—Infestation—Orlistat—obesity	0.00304	0.00373	CcSEcCtD
Deferoxamine—Renal failure—Orlistat—obesity	0.00299	0.00367	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Orlistat—obesity	0.00298	0.00366	CcSEcCtD
Deferoxamine—Urticaria—Diethylpropion—obesity	0.00293	0.0036	CcSEcCtD
Deferoxamine—Dizziness—Phenylpropanolamine—obesity	0.00293	0.0036	CcSEcCtD
Deferoxamine—Diarrhoea—Phentermine—obesity	0.0029	0.00356	CcSEcCtD
Deferoxamine—Renal failure—Sibutramine—obesity	0.00289	0.00355	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Sibutramine—obesity	0.00288	0.00354	CcSEcCtD
Deferoxamine—Asthma—Bupropion—obesity	0.00288	0.00353	CcSEcCtD
Deferoxamine—Vomiting—Phenylpropanolamine—obesity	0.00282	0.00346	CcSEcCtD
Deferoxamine—Dizziness—Phentermine—obesity	0.00281	0.00344	CcSEcCtD
Deferoxamine—Body temperature increased—Cimetidine—obesity	0.00278	0.00341	CcSEcCtD
Deferoxamine—Abdominal discomfort—Bupropion—obesity	0.00276	0.00339	CcSEcCtD
Deferoxamine—Neuropathy—Topiramate—obesity	0.00274	0.00337	CcSEcCtD
Deferoxamine—Vomiting—Phentermine—obesity	0.0027	0.00331	CcSEcCtD
Deferoxamine—Urinary tract disorder—Orlistat—obesity	0.0027	0.00331	CcSEcCtD
Deferoxamine—Dysuria—Bupropion—obesity	0.00269	0.0033	CcSEcCtD
Deferoxamine—Bradycardia—Sibutramine—obesity	0.00269	0.0033	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Topiramate—obesity	0.00268	0.00329	CcSEcCtD
Deferoxamine—Urethral disorder—Orlistat—obesity	0.00268	0.00328	CcSEcCtD
Deferoxamine—Headache—Phentermine—obesity	0.00266	0.00326	CcSEcCtD
Deferoxamine—Nausea—Phenylpropanolamine—obesity	0.00263	0.00323	CcSEcCtD
Deferoxamine—Hypersensitivity—Cimetidine—obesity	0.00259	0.00318	CcSEcCtD
Deferoxamine—Infestation NOS—Bupropion—obesity	0.00257	0.00315	CcSEcCtD
Deferoxamine—Infestation—Bupropion—obesity	0.00257	0.00315	CcSEcCtD
Deferoxamine—Visual impairment—Sibutramine—obesity	0.00255	0.00312	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—GGT1—obesity	0.00254	0.0137	CbGpPWpGaD
Deferoxamine—Diarrhoea—Diethylpropion—obesity	0.00253	0.0031	CcSEcCtD
Deferoxamine—Nausea—Phentermine—obesity	0.00252	0.00309	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Bupropion—obesity	0.00251	0.00309	CcSEcCtD
Deferoxamine—Eye disorder—Sibutramine—obesity	0.00247	0.00303	CcSEcCtD
Deferoxamine—Immune system disorder—Orlistat—obesity	0.00247	0.00303	CcSEcCtD
Deferoxamine—Tinnitus—Sibutramine—obesity	0.00246	0.00302	CcSEcCtD
Deferoxamine—Mediastinal disorder—Orlistat—obesity	0.00246	0.00302	CcSEcCtD
Deferoxamine—Dizziness—Diethylpropion—obesity	0.00244	0.003	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—PLG—obesity	0.00243	0.0131	CbGpPWpGaD
Deferoxamine—Diarrhoea—Cimetidine—obesity	0.0024	0.00295	CcSEcCtD
Deferoxamine—Angiopathy—Sibutramine—obesity	0.0024	0.00294	CcSEcCtD
Deferoxamine—Immune system disorder—Sibutramine—obesity	0.00239	0.00293	CcSEcCtD
Deferoxamine—Arrhythmia—Sibutramine—obesity	0.00236	0.0029	CcSEcCtD
Deferoxamine—Vomiting—Diethylpropion—obesity	0.00235	0.00288	CcSEcCtD
Deferoxamine—Dizziness—Cimetidine—obesity	0.00232	0.00285	CcSEcCtD
Deferoxamine—Headache—Diethylpropion—obesity	0.00231	0.00284	CcSEcCtD
Deferoxamine—Hallucination—Bupropion—obesity	0.00229	0.00281	CcSEcCtD
Deferoxamine—Muscle spasms—Orlistat—obesity	0.00228	0.0028	CcSEcCtD
Deferoxamine—Urinary tract disorder—Bupropion—obesity	0.00227	0.00279	CcSEcCtD
Deferoxamine—Connective tissue disorder—Bupropion—obesity	0.00226	0.00278	CcSEcCtD
Deferoxamine—Urethral disorder—Bupropion—obesity	0.00226	0.00277	CcSEcCtD
Deferoxamine—Vision blurred—Orlistat—obesity	0.00224	0.00275	CcSEcCtD
Deferoxamine—Visual disturbance—Topiramate—obesity	0.00224	0.00275	CcSEcCtD
Deferoxamine—Vomiting—Cimetidine—obesity	0.00223	0.00274	CcSEcCtD
Deferoxamine—Visual impairment—Bupropion—obesity	0.00222	0.00272	CcSEcCtD
Deferoxamine—Muscle spasms—Sibutramine—obesity	0.00221	0.00271	CcSEcCtD
Deferoxamine—XDH—Nucleotide metabolism—GPX1—obesity	0.00221	0.0119	CbGpPWpGaD
Deferoxamine—Headache—Cimetidine—obesity	0.0022	0.0027	CcSEcCtD
Deferoxamine—Nausea—Diethylpropion—obesity	0.00219	0.00269	CcSEcCtD
Deferoxamine—Angioedema—Orlistat—obesity	0.00217	0.00266	CcSEcCtD
Deferoxamine—Vision blurred—Sibutramine—obesity	0.00217	0.00266	CcSEcCtD
Deferoxamine—Eye disorder—Bupropion—obesity	0.00215	0.00264	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—APOB—obesity	0.00215	0.0116	CbGpPWpGaD
Deferoxamine—Tinnitus—Bupropion—obesity	0.00215	0.00264	CcSEcCtD
Deferoxamine—Angioedema—Sibutramine—obesity	0.0021	0.00258	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—SOD2—obesity	0.0021	0.0113	CbGpPWpGaD
Deferoxamine—Angiopathy—Bupropion—obesity	0.00209	0.00256	CcSEcCtD
Deferoxamine—Nausea—Cimetidine—obesity	0.00209	0.00256	CcSEcCtD
Deferoxamine—Immune system disorder—Bupropion—obesity	0.00208	0.00255	CcSEcCtD
Deferoxamine—Mediastinal disorder—Bupropion—obesity	0.00208	0.00255	CcSEcCtD
Deferoxamine—Convulsion—Orlistat—obesity	0.00206	0.00253	CcSEcCtD
Deferoxamine—Leukopenia—Sibutramine—obesity	0.00206	0.00253	CcSEcCtD
Deferoxamine—Arrhythmia—Bupropion—obesity	0.00206	0.00253	CcSEcCtD
Deferoxamine—Myalgia—Orlistat—obesity	0.00202	0.00248	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00201	0.00247	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX1—obesity	0.002	0.0108	CbGpPWpGaD
Deferoxamine—Convulsion—Sibutramine—obesity	0.00199	0.00245	CcSEcCtD
Deferoxamine—Blood creatinine increased—Topiramate—obesity	0.00199	0.00244	CcSEcCtD
Deferoxamine—Myalgia—Sibutramine—obesity	0.00196	0.0024	CcSEcCtD
Deferoxamine—Arthralgia—Sibutramine—obesity	0.00196	0.0024	CcSEcCtD
Deferoxamine—Anaphylactic shock—Orlistat—obesity	0.00194	0.00238	CcSEcCtD
Deferoxamine—Oedema—Orlistat—obesity	0.00194	0.00238	CcSEcCtD
Deferoxamine—Muscle spasms—Bupropion—obesity	0.00193	0.00237	CcSEcCtD
Deferoxamine—Infection—Orlistat—obesity	0.00193	0.00236	CcSEcCtD
Deferoxamine—Nervous system disorder—Orlistat—obesity	0.0019	0.00233	CcSEcCtD
Deferoxamine—Vision blurred—Bupropion—obesity	0.00189	0.00232	CcSEcCtD
Deferoxamine—Skin disorder—Orlistat—obesity	0.00188	0.00231	CcSEcCtD
Deferoxamine—Anaphylactic shock—Sibutramine—obesity	0.00188	0.0023	CcSEcCtD
Deferoxamine—Oedema—Sibutramine—obesity	0.00188	0.0023	CcSEcCtD
Deferoxamine—Infection—Sibutramine—obesity	0.00186	0.00229	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—MTHFR—obesity	0.00185	0.00999	CbGpPWpGaD
Deferoxamine—Shock—Sibutramine—obesity	0.00185	0.00227	CcSEcCtD
Deferoxamine—Thrombocytopenia—Sibutramine—obesity	0.00184	0.00226	CcSEcCtD
Deferoxamine—Asthma—Topiramate—obesity	0.00183	0.00225	CcSEcCtD
Deferoxamine—Angioedema—Bupropion—obesity	0.00183	0.00225	CcSEcCtD
Deferoxamine—Tachycardia—Sibutramine—obesity	0.00183	0.00225	CcSEcCtD
Deferoxamine—Skin disorder—Sibutramine—obesity	0.00182	0.00224	CcSEcCtD
Deferoxamine—Eosinophilia—Topiramate—obesity	0.00182	0.00223	CcSEcCtD
Deferoxamine—Leukopenia—Bupropion—obesity	0.00179	0.0022	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Orlistat—obesity	0.00177	0.00217	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—CRP—obesity	0.00176	0.0095	CbGpPWpGaD
Deferoxamine—Abdominal discomfort—Topiramate—obesity	0.00176	0.00216	CcSEcCtD
Deferoxamine—Hypotension—Sibutramine—obesity	0.00175	0.00215	CcSEcCtD
Deferoxamine—Paraesthesia—Orlistat—obesity	0.00174	0.00214	CcSEcCtD
Deferoxamine—Convulsion—Bupropion—obesity	0.00174	0.00213	CcSEcCtD
Deferoxamine—Dysuria—Topiramate—obesity	0.00171	0.0021	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Sibutramine—obesity	0.00171	0.0021	CcSEcCtD
Deferoxamine—Arthralgia—Bupropion—obesity	0.00171	0.00209	CcSEcCtD
Deferoxamine—Myalgia—Bupropion—obesity	0.00171	0.00209	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—APOA1—obesity	0.0017	0.00919	CbGpPWpGaD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.0017	0.00208	CcSEcCtD
Deferoxamine—Paraesthesia—Sibutramine—obesity	0.00169	0.00207	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Orlistat—obesity	0.00167	0.00205	CcSEcCtD
Deferoxamine—Dyspnoea—Sibutramine—obesity	0.00167	0.00205	CcSEcCtD
Deferoxamine—Pain—Orlistat—obesity	0.00166	0.00204	CcSEcCtD
Deferoxamine—Anaphylactic shock—Bupropion—obesity	0.00164	0.00201	CcSEcCtD
Deferoxamine—Oedema—Bupropion—obesity	0.00164	0.00201	CcSEcCtD
Deferoxamine—Infestation NOS—Topiramate—obesity	0.00163	0.00201	CcSEcCtD
Deferoxamine—Infestation—Topiramate—obesity	0.00163	0.00201	CcSEcCtD
Deferoxamine—Infection—Bupropion—obesity	0.00163	0.002	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—F2—obesity	0.00162	0.00877	CbGpPWpGaD
Deferoxamine—Gastrointestinal disorder—Sibutramine—obesity	0.00162	0.00199	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—ICAM1—obesity	0.00162	0.00873	CbGpPWpGaD
Deferoxamine—Shock—Bupropion—obesity	0.00161	0.00198	CcSEcCtD
Deferoxamine—Renal failure—Topiramate—obesity	0.00161	0.00197	CcSEcCtD
Deferoxamine—Pain—Sibutramine—obesity	0.00161	0.00197	CcSEcCtD
Deferoxamine—Nervous system disorder—Bupropion—obesity	0.0016	0.00197	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Topiramate—obesity	0.0016	0.00197	CcSEcCtD
Deferoxamine—Thrombocytopenia—Bupropion—obesity	0.0016	0.00197	CcSEcCtD
Deferoxamine—Tachycardia—Bupropion—obesity	0.0016	0.00196	CcSEcCtD
Deferoxamine—Skin disorder—Bupropion—obesity	0.00159	0.00195	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Orlistat—obesity	0.00159	0.00195	CcSEcCtD
Deferoxamine—Urticaria—Orlistat—obesity	0.00154	0.00189	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Sibutramine—obesity	0.00153	0.00188	CcSEcCtD
Deferoxamine—Body temperature increased—Orlistat—obesity	0.00153	0.00188	CcSEcCtD
Deferoxamine—Abdominal pain—Orlistat—obesity	0.00153	0.00188	CcSEcCtD
Deferoxamine—Hypotension—Bupropion—obesity	0.00153	0.00188	CcSEcCtD
Deferoxamine—Bradycardia—Topiramate—obesity	0.00149	0.00183	CcSEcCtD
Deferoxamine—Urticaria—Sibutramine—obesity	0.00149	0.00183	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Bupropion—obesity	0.00149	0.00183	CcSEcCtD
Deferoxamine—Abdominal pain—Sibutramine—obesity	0.00148	0.00182	CcSEcCtD
Deferoxamine—Body temperature increased—Sibutramine—obesity	0.00148	0.00182	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—INS—obesity	0.00147	0.00794	CbGpPWpGaD
Deferoxamine—Paraesthesia—Bupropion—obesity	0.00147	0.0018	CcSEcCtD
Deferoxamine—Hallucination—Topiramate—obesity	0.00146	0.00179	CcSEcCtD
Deferoxamine—Dyspnoea—Bupropion—obesity	0.00146	0.00179	CcSEcCtD
Deferoxamine—Urinary tract disorder—Topiramate—obesity	0.00145	0.00178	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—CCL2—obesity	0.00145	0.00781	CbGpPWpGaD
Deferoxamine—Connective tissue disorder—Topiramate—obesity	0.00144	0.00177	CcSEcCtD
Deferoxamine—Urethral disorder—Topiramate—obesity	0.00144	0.00177	CcSEcCtD
Deferoxamine—Hypersensitivity—Orlistat—obesity	0.00143	0.00175	CcSEcCtD
Deferoxamine—Visual impairment—Topiramate—obesity	0.00141	0.00174	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Bupropion—obesity	0.00141	0.00173	CcSEcCtD
Deferoxamine—Pain—Bupropion—obesity	0.0014	0.00172	CcSEcCtD
Deferoxamine—Hypersensitivity—Sibutramine—obesity	0.00138	0.0017	CcSEcCtD
Deferoxamine—Pruritus—Orlistat—obesity	0.00137	0.00168	CcSEcCtD
Deferoxamine—Eye disorder—Topiramate—obesity	0.00137	0.00168	CcSEcCtD
Deferoxamine—Tinnitus—Topiramate—obesity	0.00137	0.00168	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—SERPINE1—obesity	0.00135	0.0073	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALB—obesity	0.00135	0.00728	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CA3—obesity	0.00135	0.00727	CbGpPWpGaD
Deferoxamine—Gastrointestinal pain—Bupropion—obesity	0.00134	0.00164	CcSEcCtD
Deferoxamine—Angiopathy—Topiramate—obesity	0.00133	0.00163	CcSEcCtD
Deferoxamine—Pruritus—Sibutramine—obesity	0.00133	0.00163	CcSEcCtD
Deferoxamine—Diarrhoea—Orlistat—obesity	0.00133	0.00163	CcSEcCtD
Deferoxamine—Immune system disorder—Topiramate—obesity	0.00133	0.00163	CcSEcCtD
Deferoxamine—Mediastinal disorder—Topiramate—obesity	0.00132	0.00162	CcSEcCtD
Deferoxamine—Urticaria—Bupropion—obesity	0.0013	0.0016	CcSEcCtD
Deferoxamine—Body temperature increased—Bupropion—obesity	0.00129	0.00159	CcSEcCtD
Deferoxamine—Abdominal pain—Bupropion—obesity	0.00129	0.00159	CcSEcCtD
Deferoxamine—Diarrhoea—Sibutramine—obesity	0.00128	0.00158	CcSEcCtD
Deferoxamine—Dizziness—Orlistat—obesity	0.00128	0.00157	CcSEcCtD
Deferoxamine—Erythema—Topiramate—obesity	0.00128	0.00157	CcSEcCtD
Deferoxamine—Dizziness—Sibutramine—obesity	0.00124	0.00152	CcSEcCtD
Deferoxamine—Vomiting—Orlistat—obesity	0.00123	0.00151	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IFNG—obesity	0.00123	0.00664	CbGpPWpGaD
Deferoxamine—Muscle spasms—Topiramate—obesity	0.00123	0.00151	CcSEcCtD
Deferoxamine—Headache—Orlistat—obesity	0.00121	0.00149	CcSEcCtD
Deferoxamine—Hypersensitivity—Bupropion—obesity	0.00121	0.00148	CcSEcCtD
Deferoxamine—Vision blurred—Topiramate—obesity	0.0012	0.00148	CcSEcCtD
Deferoxamine—Vomiting—Sibutramine—obesity	0.00119	0.00146	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—PTGS2—obesity	0.00118	0.00637	CbGpPWpGaD
Deferoxamine—Headache—Sibutramine—obesity	0.00118	0.00144	CcSEcCtD
Deferoxamine—Pruritus—Bupropion—obesity	0.00116	0.00142	CcSEcCtD
Deferoxamine—Nausea—Orlistat—obesity	0.00115	0.00141	CcSEcCtD
Deferoxamine—XDH—Metabolism—GLRX—obesity	0.00115	0.00618	CbGpPWpGaD
Deferoxamine—Leukopenia—Topiramate—obesity	0.00114	0.0014	CcSEcCtD
Deferoxamine—Diarrhoea—Bupropion—obesity	0.00112	0.00137	CcSEcCtD
Deferoxamine—Nausea—Sibutramine—obesity	0.00111	0.00137	CcSEcCtD
Deferoxamine—Convulsion—Topiramate—obesity	0.00111	0.00136	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IL1B—obesity	0.0011	0.00593	CbGpPWpGaD
Deferoxamine—Myalgia—Topiramate—obesity	0.00109	0.00133	CcSEcCtD
Deferoxamine—Arthralgia—Topiramate—obesity	0.00109	0.00133	CcSEcCtD
Deferoxamine—Dizziness—Bupropion—obesity	0.00108	0.00133	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00108	0.00133	CcSEcCtD
Deferoxamine—Oedema—Topiramate—obesity	0.00104	0.00128	CcSEcCtD
Deferoxamine—Vomiting—Bupropion—obesity	0.00104	0.00128	CcSEcCtD
Deferoxamine—Infection—Topiramate—obesity	0.00104	0.00127	CcSEcCtD
Deferoxamine—Shock—Topiramate—obesity	0.00103	0.00126	CcSEcCtD
Deferoxamine—Headache—Bupropion—obesity	0.00103	0.00126	CcSEcCtD
Deferoxamine—Nervous system disorder—Topiramate—obesity	0.00102	0.00125	CcSEcCtD
Deferoxamine—XDH—Metabolism—INSIG2—obesity	0.00102	0.00551	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—OTC—obesity	0.00102	0.00551	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPM1L—obesity	0.00102	0.00551	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ETFDH—obesity	0.00102	0.00551	CbGpPWpGaD
Deferoxamine—Thrombocytopenia—Topiramate—obesity	0.00102	0.00125	CcSEcCtD
Deferoxamine—Tachycardia—Topiramate—obesity	0.00102	0.00125	CcSEcCtD
Deferoxamine—Skin disorder—Topiramate—obesity	0.00101	0.00124	CcSEcCtD
Deferoxamine—Hypotension—Topiramate—obesity	0.000974	0.0012	CcSEcCtD
Deferoxamine—Nausea—Bupropion—obesity	0.000972	0.00119	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Topiramate—obesity	0.00095	0.00117	CcSEcCtD
Deferoxamine—Paraesthesia—Topiramate—obesity	0.000936	0.00115	CcSEcCtD
Deferoxamine—XDH—Metabolism—INPP5E—obesity	0.000934	0.00504	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GPT—obesity	0.000934	0.00504	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—UQCRC2—obesity	0.000934	0.00504	CbGpPWpGaD
Deferoxamine—Dyspnoea—Topiramate—obesity	0.000929	0.00114	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Topiramate—obesity	0.0009	0.0011	CcSEcCtD
Deferoxamine—Pain—Topiramate—obesity	0.000891	0.00109	CcSEcCtD
Deferoxamine—XDH—Metabolism—ME1—obesity	0.000868	0.00469	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALDH6A1—obesity	0.000868	0.00469	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SUCLG2—obesity	0.000868	0.00469	CbGpPWpGaD
Deferoxamine—Gastrointestinal pain—Topiramate—obesity	0.000852	0.00105	CcSEcCtD
Deferoxamine—Urticaria—Topiramate—obesity	0.000828	0.00102	CcSEcCtD
Deferoxamine—Body temperature increased—Topiramate—obesity	0.000824	0.00101	CcSEcCtD
Deferoxamine—Abdominal pain—Topiramate—obesity	0.000824	0.00101	CcSEcCtD
Deferoxamine—XDH—Metabolism—PNPLA3—obesity	0.000816	0.00441	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—COX7C—obesity	0.000816	0.00441	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—UCP1—obesity	0.000816	0.00441	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—TNF—obesity	0.000797	0.0043	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CS—obesity	0.000774	0.00418	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—DGAT2—obesity	0.000774	0.00418	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SUCLA2—obesity	0.000774	0.00418	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CPS1—obesity	0.000774	0.00418	CbGpPWpGaD
Deferoxamine—Hypersensitivity—Topiramate—obesity	0.000768	0.000943	CcSEcCtD
Deferoxamine—XDH—Metabolism—LIPE—obesity	0.000738	0.00399	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—MUT—obesity	0.000738	0.00399	CbGpPWpGaD
Deferoxamine—Pruritus—Topiramate—obesity	0.000738	0.000905	CcSEcCtD
Deferoxamine—Diarrhoea—Topiramate—obesity	0.000713	0.000875	CcSEcCtD
Deferoxamine—XDH—Metabolism—DGAT1—obesity	0.000708	0.00382	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYB5A—obesity	0.000708	0.00382	CbGpPWpGaD
Deferoxamine—Dizziness—Topiramate—obesity	0.000689	0.000846	CcSEcCtD
Deferoxamine—XDH—Metabolism—ACLY—obesity	0.000681	0.00368	CbGpPWpGaD
Deferoxamine—Vomiting—Topiramate—obesity	0.000663	0.000814	CcSEcCtD
Deferoxamine—XDH—Metabolism—ENPP1—obesity	0.000658	0.00355	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALOX12—obesity	0.000658	0.00355	CbGpPWpGaD
Deferoxamine—Headache—Topiramate—obesity	0.000653	0.000802	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IL6—obesity	0.000643	0.00347	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMGCS1—obesity	0.000637	0.00344	CbGpPWpGaD
Deferoxamine—Nausea—Topiramate—obesity	0.000619	0.00076	CcSEcCtD
Deferoxamine—XDH—Metabolism—PNPLA2—obesity	0.000619	0.00334	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PFKFB3—obesity	0.000619	0.00334	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ANGPTL4—obesity	0.000619	0.00334	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ACADM—obesity	0.000619	0.00334	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PLIN1—obesity	0.000619	0.00334	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SAT1—obesity	0.000619	0.00334	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ACACB—obesity	0.000602	0.00325	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYTB—obesity	0.000602	0.00325	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—OXCT1—obesity	0.000602	0.00325	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PNLIP—obesity	0.000586	0.00317	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SRD5A1—obesity	0.000586	0.00317	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SDC3—obesity	0.000572	0.00309	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—STS—obesity	0.000559	0.00302	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP26B1—obesity	0.000559	0.00302	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HK2—obesity	0.000559	0.00302	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARD—obesity	0.000547	0.00296	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC27A1—obesity	0.000536	0.0029	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GLUL—obesity	0.000526	0.00284	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—FABP4—obesity	0.000526	0.00284	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HSD11B1—obesity	0.000499	0.00269	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—UCP3—obesity	0.000499	0.00269	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—UCP2—obesity	0.000499	0.00269	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ECHS1—obesity	0.000499	0.00269	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ADH1B—obesity	0.000491	0.00265	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GPAM—obesity	0.000483	0.00261	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARGC1B—obesity	0.000483	0.00261	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ACSL1—obesity	0.000483	0.00261	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—FADS1—obesity	0.000469	0.00253	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HADH—obesity	0.000469	0.00253	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PCK1—obesity	0.000469	0.00253	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ACP5—obesity	0.000456	0.00246	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—G6PD—obesity	0.000444	0.0024	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SREBF2—obesity	0.000439	0.00237	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HK1—obesity	0.000439	0.00237	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LPA—obesity	0.000424	0.00229	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LPIN1—obesity	0.000415	0.00224	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOA5—obesity	0.000406	0.00219	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CLOCK—obesity	0.000388	0.00209	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC22A1—obesity	0.000388	0.00209	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GLP1R—obesity	0.000378	0.00204	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SULT2A1—obesity	0.000378	0.00204	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—DPYD—obesity	0.000372	0.00201	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PRKAR2B—obesity	0.000358	0.00193	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—DCN—obesity	0.000355	0.00192	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CPT1A—obesity	0.000346	0.00187	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NAMPT—obesity	0.000339	0.00183	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LIPC—obesity	0.000337	0.00182	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GCK—obesity	0.000337	0.00182	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOC3—obesity	0.000335	0.00181	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CETP—obesity	0.000325	0.00175	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SDC1—obesity	0.000321	0.00173	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AKR1C3—obesity	0.000316	0.00171	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SCARB1—obesity	0.000311	0.00168	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SREBF1—obesity	0.000302	0.00163	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GOT2—obesity	0.000294	0.00159	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—FASN—obesity	0.000288	0.00155	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—BCHE—obesity	0.000286	0.00155	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP2E1—obesity	0.000276	0.00149	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NQO1—obesity	0.000273	0.00147	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GCG—obesity	0.000262	0.00141	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC2A4—obesity	0.000262	0.00141	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYCS—obesity	0.000259	0.0014	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GOT1—obesity	0.000254	0.00137	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GGT1—obesity	0.000254	0.00137	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NCOA1—obesity	0.00025	0.00135	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP19A1—obesity	0.000246	0.00133	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—STK11—obesity	0.000246	0.00133	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—COMT—obesity	0.000229	0.00124	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GNB3—obesity	0.000226	0.00122	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARGC1A—obesity	0.000226	0.00122	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMOX1—obesity	0.000225	0.00121	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GNAS—obesity	0.00022	0.00119	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOB—obesity	0.000215	0.00116	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LPL—obesity	0.000206	0.00111	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GPX1—obesity	0.000201	0.00108	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CD36—obesity	0.000195	0.00105	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—MTHFR—obesity	0.000185	0.000999	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARA—obesity	0.000182	0.00098	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AGT—obesity	0.000176	0.000949	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOE—obesity	0.000172	0.00093	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CAV1—obesity	0.000171	0.000922	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOA1—obesity	0.00017	0.000919	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3CG—obesity	0.000155	0.000839	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARG—obesity	0.00015	0.00081	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—POMC—obesity	0.000148	0.000799	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—INS—obesity	0.000147	0.000795	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3CD—obesity	0.000137	0.000738	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALB—obesity	0.000135	0.000728	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NOS3—obesity	0.000129	0.000697	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3R1—obesity	0.000129	0.000697	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3CB—obesity	0.000119	0.000643	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PTGS2—obesity	0.000118	0.000637	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3CA—obesity	7.26e-05	0.000392	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AKT1—obesity	5.93e-05	0.00032	CbGpPWpGaD
